← Leaderboards
Subbaya Subramanian
University Of Minnesota
$822,006
Attributed
$1,086,695
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $394.5K · FY2017–25$500K$375K$250K$125K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,086,695 · 4
By mechanism
R21$791,565 · 2
R03$295,130 · 2
Top collaborators
- Timothy J. Griffin2 shared
- Pratik D Jagtap2 shared
Most similar at University Of Minnesota
Same institution · by research overlap
- Kathryn L Schwertfeger$10,989,964
- Timothy J. Griffin$7,286,622
- Pratik D Jagtap$468,600
Others in their field
Other Emerging Leaders on “Colon Cancer Patients”
- Rachana Agarwal · Leidos Biomedical Research, Inc.$15,241,462
- Kathleen Nicol · Research Inst Nationwide Children'S Hosp$7,187,946
- Xingyi Guo · Vanderbilt University Medical Center$6,698,295
- Gary Fanger · Rise Therapeutics, Llc$5,874,267
- Kamila Naxerova · Massachusetts General Hospital$5,403,066
- Dustin A Deming · University Of Wisconsin-Madison$5,391,375
Research focus
Colon Cancer PatientsImmune ResponseCessation Of LifeColorectal CancerTumorSamplingMalignant NeoplasmsMetabolicMetabolomicsOrganoidsTumor TissueInvestigationInfiltrationTumor MicroenvironmentUnited StatesMicrobiotaCellsMicrobiomeNormal Tissue MorphologyMicrobialCancer EtiologyImmuneEnvironmentImproved Outcome
Grant awards (7)
LAT1 as a Novel Therapeutic Target in Colorectal Cancer$394,532
R21 · FY2025 · CA · contact PI
Metabolites regulating macrophage function in colorectal cancer$74,274
R03 · FY2024 · CA · contact PI
Microbiome-derived regulators of therapy-resistant colorectal tumors$178,483
R21 · FY2023 · CA
Metabolites regulating macrophage function in colorectal cancer$74,274
R03 · FY2023 · CA · contact PI
Microbiome-derived regulators of therapy-resistant colorectal tumors$218,550
R21 · FY2022 · CA
Atypical Chemokine Receptor 4 (ACKR4) in Anti-tumor Immunity in colorectal cancer$73,490
R03 · FY2018 · CA · contact PI
Atypical Chemokine Receptor 4 (ACKR4) in Anti-tumor Immunity in colorectal cancer$73,092
R03 · FY2017 · CA · contact PI